India to Brazil: Gliclazide Export Trade Route
India has recorded 591 verified shipments of Gliclazide exported to Brazil, representing a combined trade value of $20.7M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $35.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 37% of total export value with 219 shipments worth $7.7M USD. On the buying side, TORRENT DO BRASIL LTDA is the largest importer in Brazil with $3.7M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Gliclazide corridor is one of India's established pharmaceutical export routes, with 591 shipments documented worth a combined $20.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 37% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $35.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 27.5%, placing it at rank #19 among India's top gliclazide export destinations globally.
On the import side, key buyers of Indian gliclazide in Brazil include TORRENT DO BRASIL LTDA, TORRENT DO BRASIL LTDA , RANBAXY FARMACEUTICA LTDA : and 26 others. TORRENT DO BRASIL LTDA is the single largest importer with 144 shipments valued at $3.7M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#19
- Annual growth+27.5%
- Demand growth+23.1%
- Regulatory ease66/100
Top 10 Indian Gliclazide Exporters to Brazil
Showing top 10 of 8 Indian suppliers exporting Gliclazide to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $35.0K per shipment | 219 | $7.7M | 37.0% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $58.7K per shipment | 67 | $3.9M | 19.0% |
| 3 | TORRENT PHARMACEUTICALS LTD Avg $34.8K per shipment | 82 | $2.9M | 13.8% |
| 4 | TORRENT PHARMACEUTICALS LTD Avg $22.9K per shipment | 122 | $2.8M | 13.5% |
| 5 | TORRENT PHARMACEUTICALS LIMITED Avg $31.5K per shipment | 80 | $2.5M | 12.2% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $74.3K per shipment | 12 | $891.9K | 4.3% |
| 7 | ACME PLAZA, GROUND FLOOR, Avg $15.0K per shipment | 3 | $44.9K | 0.2% |
| 8 | RV LIFESCIENCES LIMITED Avg $1 per shipment | 6 | $6 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting gliclazide to Brazil, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD , TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, ACME PLAZA, GROUND FLOOR,, RV LIFESCIENCES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 219 shipments worth $7.7M USD, giving it a 37% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Top 10 Gliclazide Importers in Brazil
Showing top 10 of 29 known buyers in Brazil receiving Gliclazide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gliclazide in Brazil include TORRENT DO BRASIL LTDA, TORRENT DO BRASIL LTDA , RANBAXY FARMACEUTICA LTDA :, M/S. RANBAXY FARMACEUTICA LTDA : , TORRENT DO BRASIL LIMITEDA, among 29 total buyers. The largest importer is TORRENT DO BRASIL LTDA, accounting for $3.7M USD across 144 shipments — representing 18% of all gliclazide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT DO BRASIL LTDA | 144 | $3.7M | 17.8% |
| 2 | TORRENT DO BRASIL LTDA | 82 | $2.9M | 13.8% |
| 3 | RANBAXY FARMACEUTICA LTDA : | 76 | $2.3M | 11.0% |
| 4 | M/S. RANBAXY FARMACEUTICA LTDA : | 38 | $2.0M | 9.8% |
| 5 | TORRENT DO BRASIL LIMITEDA | 58 | $1.6M | 7.8% |
| 6 | M S RANBAXY FARMACEUTICA LTDA | 9 | $766.5K | 3.7% |
| 7 | M/S. SUN FARMACEUTICA DO BRASIL LTD | 5 | $759.0K | 3.7% |
| 8 | MS RANBAXY FARMACEUTICA LIMITED | 7 | $750.3K | 3.6% |
| 9 | M/S. SUN FARMACEUTICA DO BRAZIL LTD | 13 | $731.0K | 3.5% |
| 10 | RANBAXY FARMACEUTICA LIMITED | 9 | $667.9K | 3.2% |
Showing top 10 of 29 Gliclazide importers in Brazil on this route.
Top 10 Gliclazide Formulations Imported by Brazil
Showing top 10 of 237 product formulations shipped on the India to Brazil Gliclazide route, ranked by trade value
Brazil imports a wide range of gliclazide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — AZUKON MR TABLET ( GLICLAZIDE MODIFIED R — accounts for $917.2K USD across 25 shipments. There are 237 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AZUKON MR TABLET ( GLICLAZIDE MODIFIED R | 25 | $917.2K | 4.4% |
| 2 | GLICLAZIDE SUN TAB 30MG 20X50b(OF)BR PA | 4 | $712.5K | 3.4% |
| 3 | AZUKON MR TABLET GLICLAZIDE 30MG MODIFIED RELEASE TABLETS NOS SIZE 10X10 TABLETS | 6 | $589.6K | 2.8% |
| 4 | GLICLAZIDE TAB 60 MG 50X10b PACK:BOX50X1 | 8 | $489.5K | 2.4% |
| 5 | GLICLAZIDE TAB 60mg contains GliclazidePACK : Box60s | 4 | $452.7K | 2.2% |
| 6 | GLICLAZIDE RXY TAB 30mg 50X10B EACH CONTAINS: GLICLAZIDE MODIFIED RELEASE TABLETS 30 mg : PACK : Box50x10s | 11 | $435.4K | 2.1% |
| 7 | GLICLAZIDE SUN TAB 30MG 10X50b(OF)BR PAC | 7 | $424.6K | 2.1% |
| 8 | AZUKON MR TABLET (GLICLAZIDE MODIFIED RE | 9 | $349.6K | 1.7% |
| 9 | GLICLAZIDE SUN TAB 30MG 10X50BOF BR EA | 3 | $310.6K | 1.5% |
| 10 | GLICLAZIDE TAB 60MG 3X10b BRAZ PACK:BOX3 | 4 | $295.9K | 1.4% |
Showing top 10 of 237 Gliclazide formulations imported by Brazil on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 112 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's gliclazide exports to Brazil are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 219 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD — together account for 70% of total trade value on this route. The average shipment value of $35.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gliclazide sun tab 30mg 20x50b(of)br pa and azukon mr tablet gliclazide 30mg modified release tablets nos size 10x10 tablets, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TORRENT DO BRASIL LTDA is the largest importer with 144 shipments worth $3.7M USD — representing 18% of all gliclazide imports from India on this route. A total of 29 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $20.7M
- Avg. Shipment
- $35.0K
- Suppliers
- 8
- Buyers
- 29
- Transit (Sea)
- ~33 days
- Annual Growth
- +27.5%
Related Analysis
Reverse Direction
Brazil → India — Gliclazide (Import)Other Gliclazide Routes
Unlock the Full India to Brazil Gliclazide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 591 shipments on this route.
Frequently Asked Questions — India to Brazil Gliclazide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gliclazide to Brazil?
The leading Indian exporters of Gliclazide to Brazil are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , TORRENT PHARMACEUTICALS LTD . SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 37% of total trade value on this route.
Q What is the total value of Gliclazide exports from India to Brazil?
India exports Gliclazide to Brazil worth approximately $20.7M USD across 591 recorded shipments. The average value per shipment is $35.0K USD.
Q Which ports does India use to ship Gliclazide to Brazil?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 112 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Brazil for Gliclazide?
The average transit time for Gliclazide shipments from India to Brazil is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Brazil Gliclazide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.5% with demand growth tracking at 23.1%. The route is ranked #19 among India's top Gliclazide export destinations globally.
Q How many suppliers are active on the India to Brazil Gliclazide route?
There are currently 8 active Indian suppliers exporting Gliclazide to Brazil. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 37% of total shipment value.
Q Who are the main importers of Gliclazide from India in Brazil?
The leading importers of Indian Gliclazide in Brazil include TORRENT DO BRASIL LTDA, TORRENT DO BRASIL LTDA , RANBAXY FARMACEUTICA LTDA :, M/S. RANBAXY FARMACEUTICA LTDA : , TORRENT DO BRASIL LIMITEDA. TORRENT DO BRASIL LTDA is the largest buyer with 144 shipments worth $3.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Gliclazide.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 29 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 591 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
591 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists